Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness

Metabolism: Clinical and Experimental

Volumn 58, Issue 1, 2009, Pages 102-108

  Jernås, Margareta ^a   Olsson, Bob ^a   Sjöholm, Kajsa ^a   Sjögren, Anders ^b   Rudemo, Mats ^b   Nellgård, Bengt ^a   Carlsson, Lena M S ^a   Sjöström, C David ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; GLYCOPROTEIN; MESSENGER RNA; NEUTRAL INSULIN; PHOSPHOLIPASE A2; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CRITICAL ILLNESS; CYTOKINE PRODUCTION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN INFUSION; INSULIN RESISTANCE; INTENSIVE CARE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUBARACHNOID HEMORRHAGE;

ACUTE-PHASE PROTEINS; ADIPOKINES; ADIPOSE TISSUE; BIOPSY; BLOOD GLUCOSE; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SUBARACHNOID HEMORRHAGE;

EID: 57049140500     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.08.012     Document Type: Article

References (36)

1. Bernard C. Lecons sur les phénoménes de la vie communs aux animaux et aux végétaux (1878), J.B. Bailliére et fils, Paris, France
2. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 17 (2001) 107-124
3. Thorell A., Nygren J., and Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 2 (1999) 69-78
4. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
5. Andreelli F., Jacquier D., and Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care 9 (2006) 124-130
6. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184 (2005) 285-293
7. Feve B., Bastard J.P., and Vidal H. Relationship between obesity, inflammation and insulin resistance: new concepts. C R Biol 329 (2006) 587-597 [discussion 653-5]
8. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29 (2001) 365-371
9. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 4 (2003) 249-264
10. Kristiansson E., Sjögren A., Rudemo M., and Nerman O. Quality optimised analysis of general paired microarray experiments. Stat Appl Genet Mol Biol 5 (2006) Article10
11. Gabrielsson B.G., Olofsson L.E., Sjögren A., et al. Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 13 (2005) 649-652
12. Trayhurn P., and Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92 (2004) 347-355
13. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
14. Williams R.B., Chan E.K., Cowley M.J., and Little P.F. The influence of genetic variation on gene expression. Genome Res 17 (2007) 1707-1716
15. Bao Y., Bing C., Hunter L., Jenkins J.R., Wabitsch M., and Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 579 (2005) 41-47
16. Bing C., Bao Y., Jenkins J., et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A 101 (2004) 2500-2505
17. Coppack S.W., Jensen M.D., and Miles J.M. In vivo regulation of lipolysis in humans. J Lipid Res 35 (1994) 177-193
18. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
19. Holme I., Aastveit A.H., Jungner I., and Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 264 (2008) 30-38
20. Tzanavari T., Bing C., and Trayhurn P. Postnatal expression of zinc-alpha2-glycoprotein in rat white and brown adipose tissue. Mol Cell Endocrinol 279 (2007) 26-33
21. Oh D.K., Ciaraldi T., and Henry R.R. Adiponectin in health and disease. Diabetes Obes Metab 9 (2007) 282-289
22. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580 (2006) 2917-2921
23. Behre C.J., Gummesson A., Jernås M., et al. Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome. Metabolism 56 (2007) 1022-1028
24. Graham T.E., Yang Q., Bluher M., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354 (2006) 2552-2563
25. Vitkova M., Klimcakova E., Kovacikova M., et al. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 92 (2007) 2330-2335
26. Powell-Tuck J. Nutritional interventions in critical illness. Proc Nutr Soc 66 (2007) 16-24
27. Janke J., Engeli S., Boschmann M., et al. Retinol-binding protein 4 in human obesity. Diabetes 55 (2006) 2805-2810
28. Blaner W.S. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 10 (1989) 308-316
29. Rallidis L.S., Vikelis M., Panagiotakos D.B., et al. Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis 189 (2006) 193-197
30. Nesto R. C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med 21 (2004) 810-817
31. Yuan G., Chen X., Ma Q., et al. C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes. J Endocrinol 194 (2007) 275-281
32. Yang R.Z., Lee M.J., Hu H., et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS medicine 3 (2006) e287
33. Sjöholm K., Palming J., Olofsson L.E., et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 90 (2005) 2233-2239
34. Pruzanski W., Vadas P., Stefanski E., and Urowitz M.B. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol 12 (1985) 211-216
35. Crowl R.M., Stoller T.J., Conroy R.R., and Stoner C.R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266 (1991) 2647-2651
36. Varastehpour A., Radaelli T., Minium J., et al. Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity. J Clin Endocrinol Metab 91 (2006) 248-255